In recent years, several studies have presented evidence suggesting a potential role for
metformin in anti-cancer therapy. Preclinical studies have demonstrated several anticancer …

Immunotherapy is among the most rapidly evolving treatment strategies in oncology. The
therapeutic potential of immune-checkpoint inhibitors is exemplified by the recent hail of Food …

Wnt/β-catenin signaling, a highly conserved pathway through evolution, regulates key cellular
functions including proliferation, differentiation, migration, genetic stability, apoptosis, and …

Immunotherapy has emerged as a promising treatment modality in cancer therapy. With
improved understanding of how to tip the balance of immune homeostasis, novel therapeutics …

The fibroblast growth factor/fibroblast growth factor receptor (FGF/FGFR) is a tyrosine kinase
signaling pathway that has a fundamental role in many biologic processes including …

Background Entrectinib is a potent inhibitor of tropomyosin receptor kinase (TRK) A, B, and
C, which has been shown to have anti-tumour activity against NTRK gene fusion-positive …

Epithelial-mesenchymal transition (EMT) is able to drive metastasis during progression of
multiple cancer types, including non-small cell lung cancer (NSCLC). As resistance to …

Tumor mutational burden (TMB) in circulating tumor DNA (ctDNA) has shown promise in
predicting benefit from PD-L1/PD-1 inhibitors in retrospective studies. Aiming to assess blood …

Purpose: Immune checkpoint blockade has improved outcomes across tumor types; little is
known about the efficacy of these agents in rare tumors. We report the results of the (…

While overexpression of several aquaporins (AQPs) has been reported in different types of
human cancer, the role of AQPs in carcinogenesis has not been clearly defined. Here, by …